bs-41405P [Protein]
Recombinant SARS-CoV-2 Spike Protein S1 , N-His
www.biossusa.com
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Source: Recombinant SARS-CoV-2 Spike Protein S1 , N-His protein is expressed in E.coli with N-His. It contains the amino acid sequence of 16-685aa.

Storage Buffer: Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5% trehalose is added as a protectant before lyophilization.

Storage: The product should be stored at -70°C or -20°C.

Background:

Conc = ≥0.5 mg/ml The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.

Sequence: 16-685aa

Size: 20ug, 1mg, 100ug

Applications: WB(1:300-5000)
ELISA(1:500-1000)

Mol. Wt.: 76


Species: SARS-CoV-2

For research use only. Not intended for diagnostic or therapeutic use.